Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer

OBJECTIVE: Immune checkpoint inhibitors (ICIs) have achieved remarkable results in cancer treatments. However, there is no effective predictive biomarker for gastrointestinal (GI) cancer. METHODS: We conducted integrative analyses of the genomic and survival data of ICI-treated GI cancer patients fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yujiao, Jiao, Xi, Li, Shuang, Chen, Huan, Wei, Xin, Liu, Chang, Gong, Jifang, Zhang, Xiaotian, Wang, Xicheng, Peng, Zhi, Qi, Changsong, Wang, Zhenghang, Wang, Yanni, Zhuo, Na, Zou, Jianling, Zhang, Henghui, Li, Jian, Shen, Lin, Lu, Zhihao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425187/
https://www.ncbi.nlm.nih.gov/pubmed/34570439
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425187/
https://www.ncbi.nlm.nih.gov/pubmed/34570439
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0708

Ejemplares similares